The new version of syngo.via supports treatment decision-making in oncology

325

The widely varying progressions of cancer require comprehensive diagnostics, an early check of treatment, and the exchange of information with colleagues. Siemens says that its new version of the diagnostics software syngo.via supports the treating physician in making decisions regarding treatment in oncology through a comprehensive portfolio of applications across imaging systems, treatments, and disciplines.

Imaging procedures play an important role in treatment planning. Multimodal image material not only provides information for a precise assessment of the tumour with regard to its position, morphology and metabolism, but it also forms the basis for radiotherapy planning. The application syngo.via RT Image Suite supports the radiotherapy oncologists in the demanding task of optimally using clinical images from various sources such as CT, MRT or PET-CT in order to contour the tumour to be irradiated and the surrounding tissue to be spared.

Another part of the oncology software portfolio is the application syngo.MR OncoCare. Siemens says that this software allows an early, quantitative evaluation of the response of the tumour to the treatment. It allows conclusions to be drawn about the success of the selected treatment method and, if necessary, this method can be adapted. Thus, the patient is spared from the continuation of ineffective treatment and the unnecessary costs associated with it.

In order to define the best possible treatment for each individual patient and successfully treat cancer, a wide variety of medical disciplines are drawn upon. Their representatives come together in regular, interdisciplinary meetings on this topic in so-called tumour boards. Syngo.MI Offline Oncoboard provides an IT solution in order to be able to present syngo.via findings of the various imaging procedures even on a standard PC and independently of a network connection.

(Visited 27 times, 1 visits today)